Background: Catheter Ablation of Common Atrioventricular Nodal Reentry Tachycardia is the commonest type of Supraventricular Tachycardia referred to the Electrophysiology lab and it constitutes about 70% of the arrhythmias admitted to the Emergency Department. The mechanism of Catheter Ablation of Common Atrioventricular Nodal Reentry Tachycardia is reentry where the slow pathway sited at the lower posterior region of Koch's triangle near the coronary sinus orifice while the fast pathway higher up near the His bundle at the antero superior aspect of Koch's triangle. The catheter ablation becoming first line therapy in drug refractory cases and may be first option before drug treatment according to the patient preference or the hemodynamic deterioration due to the Supraventricular Tachycardia. Patients and Methods: Seventy patients with Catheter Ablation of Common Atrioventricular Nodal Reentry Tachycardia were selected from a total Supraventricular Tachycardia cases of 106 patients referred to the Catheter lab for ablation. Standard technique for Electrophysiological study done to induce the tachycardia. Three Electrophysiological catheters used in 90% of cases which include RA, His, RV and a fourth catheter introduced at the CS in 10% of the cases. Atrial programmed stimulation with S1 400msc, S2 300-230 and S3 of 250-220msc used to induce the Supraventricular Tachycardia in 85% of the cases and ventricular programmed stimulation in 15% of the cases. Differentiation of the AVNRT from Atrial Tachycardia and Atrio Ventricular Tachycardia done by ventricular entrainment where the PPI-TCL more than 115msc considered supportive of Catheter Ablation of Common Atrioventricular Nodal Reentry Tachycardia and the pattern post VP is VAV where AT is excluded. Dry ablation catheter of 4 mm tip used to modify the SP near the CS OS .The appearance of JR or JBs was a sign of effective application of the RF. The success of ablation was indicated by failure to induce the tachycardia with A and VPS. The success rate was 90% with 4 years follow up and the recurrence rate was 5%. Complete Heart Block developed in 3% who needed Permanent Pacemaker. The average total procedure time 45minutes and fluoroscopy time average 5 minutes.
Introduction
Atrioventricular nodal reentry tachycardia (AVNRT) is the most common form of regular narrow complex tachycardia (RNCT) referred to the catheter laboratory for ablation therapy 1 . AVNRT more commonly occurs in patients without structural heart disease, it is more common in females than males. 1, 2 . The mechanism of AVNRT is reentry using two pathways one is slow and the other is fast , they are anatomically located at the triangle of Koch at the right atrium, the fast is close to the His bundle while the slow is just above the coronary sinus os [3] [4] [5] . The slow pathway is the antegrade conducting pathway and the fast is the retrograde conducting in the common type of AVNRT which is labeled accordingly as the slow/fast (s/f) type while the uncommon type is characterized by the fast pathway is conducting antegradely and the slow one conducting retrogradely and called fast/slow (f/s) type . 1, 2 The superficial Electrocardiographic features of AVNRT are: 1, RNCT.2, either no P' seen where it is embedded within the QRS or P' seen just after the QRS as a pseudo r wave in V1 and aVR and /or pseud s in leads II,II and aVF 2 , Figure 1 .
Figure 1. Twelve leads ECG of SVT showing RNCT of short RP long PR type and pseudo r wave at V1 and aVR and pseudo s wave at lead II (arrows) . These features suggesting common s/f type AVNRT.
The electrophysiological characteristics include: 1, AH interval jump during atrial programmed stimulation and induction of the tachycardia.2, during SVT a short VA interval less than 80msc. 3, with ventricular over drive stimulation (ventricular entrainment) during the SVT a VAV pattern seen with a post pacing interval (PPI) -Tachycardia Cycle length (TCL) is more than 118msc. 2 Figure 2 . Catheter radiofrequency catheter ablation therapy (CRFAT) targeting the fast or the slow pathway has been used for more than two decades. [3] [4] [5] [6] The slow pathway ablation became the most widely used. 1, 2 In Iraq the first slow pathway CRFAT was done at Kadhymia teaching hospital in the year of 2001 and at Nasiriya Heart Centre in the year of 2007. 7 In Kurdistan it was done in the year of 2011 at Alhassani cardiac center at Sulaimanya. More recently more cases are done using the new system of Cartoo and the Ensite at Najaf and Nasiriya heart centers. 
Patients and Methods

Results
Among the 70 patients included in this study 68 (97%) patients had acute success with non inducibilty of the tachycardia at the end of the ablation procedure. In two patients the procedure The follow up period ranged from 1.5-6 years. There was a recurrence in two patients after 6 months and one year in both a second ablation done and followed for 2 years with no recurrence. All patients discharged from the hospital in the same day within 4-8 hours after the procedure and they are advised to rest for 24 hours after which they can resume normal daily life activities.
Discussion
AVNRT of s/f type accounts about 85% of the AVNRT and 75% of the RNCT seen in the ED or the cath lab. The presenting symptomatologies previously described by Wood were palpitation in 96%, dizziness in 75%, dyspnea in 47%, and syncope in 0.5%. 8 We noticed palpitation in 100%, dizziness in 35%, and syncope in 20% and dyspnea in 40 %. AVNRT is commonly seen in structurally normal heart but patients with structural heart disease occasionally develop AVNRT. In our series only three patients (4%) have previous IHD. While in other's series structural heart disease seen in 6-19%. [8] [9] [10] [11] The typical s/f type is far more common than the uncommon f/s type. [10] [11] [12] . In our series only s/f type are included. The treatment of AVNRT depends on the effect of the tachycardia on the hemodynamics and life activities of the patient. Findings a cure has always been the main goal of therapy. [11] [12] [13] . Drug treatment might be effective in minority of patients but it has to be lifelong therapy with all the possible side effects .Patient compliance to drug therapy, the drugs side effects and the cost are the three main limiting factors for the life lasting drugs therapy. When ablation therapy first used by delivering DC shock or open heart surgery ablation it gave a hope for a future easier, safer and highly effective ablation procedure and that is when CRFAT came over and the energy source with RF became so well controlled and refined the ablation results became highly encouraging to achieve total cure of many arrhythmias and on the top of the list is the AVNRT. The excellent outcome of ablation is mainly due to the development of anatomical and electrical mapping procedures and precisely defining the slow pathway ablation site. 14, 15, 16 To achieve high success rate in AVNRT ablation we need: 1, well set EP and ablation generator systems. 2, trained medical and technical staff. 3, Reliable X ray fluoroscopy set up with RAO and LAO projection. 4, EP and ablation catheters. We started with self-training program locally at Kadhymia teaching hospital, Nasiriya heart center and then at Alhassani cardiac center in Sulaimanya where the cases included in this study. Our acute success rate was 98% and the long term success was 100% where in two patients recurrence occurred and needed another SP ablation where no recurrence within two years follow up . The reported recurrence rate ranges from 3-6% . 5, 18-22 . Complete atrio ventricular block (AVB) developed in three patients, in two permanent pacemaker was implanted and in one the AVB resolved after 24 hours, these results are comparable to other series. 16 The appearance of junctional rhythm during RF delivery is considered a marker of effective RF delivery and then as a successful ablation by many authors. 17, [18] [19] [20] . However the absence of JR does not increase the risk of recurrence of the AVNRT but technically it indicate non effective RF delivery . 5, 21 -22 CRFAT improves health related quality of life to a greater extent than do medications and cost wise it is less expensive therapy compared to long life lasting drug therapy among patients who have 1-2 attacks of SVT per month. 17, 18 
